KCNB1 and epilepsy: Previous studies have suggested that a combination of lamotrigine and sodium valproate should be considered in patients with refractory epilepsy, as its efficacy appears to be independent of seizure type or demographics of the patient.[16] In summary, our treatment approach may be considered as a reliable option for the treatment of KCNB1-related epilepsy.